These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18503483)

  • 1. Recovery of tacrolimus-associated brachial neuritis after conversion to everolimus in a pediatric renal transplant recipient--case report and review of the literature.
    Al Masri O; Fathallah W; Quader S
    Pediatr Transplant; 2008 Dec; 12(8):914-7. PubMed ID: 18503483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
    Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
    Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter trial of everolimus in pediatric renal transplant recipients: results at three year.
    Ettenger R; Hoyer PF; Grimm P; Webb N; Loirat C; Mahan JD; Mentser M; Niaudet P; Offner G; Vandamme-Lombaerts R; Hexham JM;
    Pediatr Transplant; 2008 Jun; 12(4):456-63. PubMed ID: 18466433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.
    Kaczmarek I; Schmauss D; Sodian R; Beiras-Fernandez A; Oberhoffer M; Daebritz S; Schoenberg SO; Reichart B
    J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
    Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
    Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of migraine with aura due to tacrolimus therapy in a liver transplant recipient successfully treated with sirolimus substitution.
    Toth CC; Burak K; Becker W
    Headache; 2005 Mar; 45(3):245-6. PubMed ID: 15836601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus rescue for tacrolimus-associated post-transplant autoimmune hemolytic anemia.
    Valentini RP; Imam A; Warrier I; Ellis D; Ritchey AK; Ravindranath Y; Shapiro R; Moritz ML
    Pediatr Transplant; 2006 May; 10(3):358-61. PubMed ID: 16677361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from tacrolimus to cyclosporine for a non-dose-dependent tacrolimus-induced toxicity, a pediatric kidney transplant recipient case report.
    Ghio L; Ferraresso M; Giani M; Mihatsch M; Edefonti A
    Transplant Proc; 2004 Jun; 36(5):1332-5. PubMed ID: 15251325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation.
    Chegounchi M; Hanna MG; Neild GH
    BMC Nephrol; 2006 Mar; 7():7. PubMed ID: 16573841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late conversion to everolimus complicated with necrotizing glomerulonephritis in a renal allograft recipient: case report.
    Nowacka-Cieciura E; Perkowska-Ptasińska A; Sulikowska-Rowińska A; Cieciura T; Wazna E; Durlik M
    Transplant Proc; 2009; 41(1):441-5. PubMed ID: 19249576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.
    De Simone P; Metselaar HJ; Fischer L; Dumortier J; Boudjema K; Hardwigsen J; Rostaing L; De Carlis L; Saliba F; Nevens F
    Liver Transpl; 2009 Oct; 15(10):1262-9. PubMed ID: 19790150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus in renal transplantation.
    Morath C; Arns W; Schwenger V; Mehrabi A; Fonouni H; Schmidt J; Zeier M
    Nephrol Dial Transplant; 2007 Sep; 22 Suppl 8():viii61-viii65. PubMed ID: 17890266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease--a common and serious complication after intestinal transplantation.
    Herlenius G; Fägerlind M; Krantz M; Mölne J; Olausson M; Gäbel M; Friman V; Oltean M; Friman S
    Transplantation; 2008 Jul; 86(1):108-13. PubMed ID: 18622286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
    Albano L; Berthoux F; Moal MC; Rostaing L; Legendre C; Genin R; Toupance O; Moulin B; Merville P; Rerolle JP; Bayle F; Westeel PF; Glotz D; Kossari N; Lefrançois N; Charpentier B; Blanc AS; Di Giambattista F; Dantal J;
    Transplantation; 2009 Jul; 88(1):69-76. PubMed ID: 19584683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
    Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J
    Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
    Tory R; Sachs-Barrable K; Goshko CB; Hill JS; Wasan KM
    Transplantation; 2009 Jul; 88(1):62-8. PubMed ID: 19584682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus.
    Yuksekkaya HA; Arikan C; Yazici A; Baran M; Aydogdu S; Kilic M
    Pediatr Transplant; 2009 May; 13(3):375-8. PubMed ID: 18452496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.